Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.22.2.2
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Accounts Receivable, Allowance for Credit Loss, Current $ 339 $ 174
Notes Payable, Related Parties, Noncurrent $ 0 $ 7,498
Common stock, par value per share $ 0.0001  
Series A Preferred Stock    
Preferred stock, par value per share $ 0.0001 $ 0.0001
Preferred stock, authorized 0 12,671,911
Preferred stock, shares issued 0 21,615,723
Preferred stock, outstanding 0 21,615,723
Preferred Stock, Liquidation Preference, Value   $ 52,809
Series B Preferred Stock    
Preferred stock, par value per share $ 0.0001 $ 0.0001
Preferred stock, authorized 0 4,869,754
Preferred stock, shares issued 0 8,306,818
Preferred stock, outstanding 0 8,306,818
Preferred Stock, Liquidation Preference, Value   $ 35,228
Series C Preferred Stock    
Preferred stock, par value per share $ 0.0001 $ 0.0001
Preferred stock, authorized 0 9,126,525
Preferred stock, shares issued 0 12,804,176
Preferred stock, outstanding 0 12,804,176
Preferred Stock, Liquidation Preference, Value   $ 65,222
Common Class A    
Common stock, par value per share $ 0.0001 $ 0.0001
Common stock, authorized 1,000,000,000 55,000,000
Common stock, Issued 139,096,000 17,664,015
Common stock, outstanding 139,096,000 17,664,015
Class B common stock    
Common stock, par value per share $ 0.0001 $ 0.0001
Common stock, authorized 15,000,000  
Common stock, Issued 12,058,614  
Common stock, outstanding 12,058,614